Skip to main content
Clinical Trials/NCT02017314
NCT02017314
Unknown
Phase 4

Correlation of Postoperative VAS Values and Body Mass Index in Patients Undergoing Abdominal Surgery: A Clinical Trial

Istanbul University1 site in 1 country100 target enrollmentNovember 2013
ConditionsMorbid Obesity
InterventionsMorphine

Overview

Phase
Phase 4
Intervention
Morphine
Conditions
Morbid Obesity
Sponsor
Istanbul University
Enrollment
100
Locations
1
Primary Endpoint
Pain Scores on the Visual Analog Scale
Last Updated
12 years ago

Overview

Brief Summary

The aim of the study is to observe if any correlation between Body mass index and VAS values exists in patients who has gone under abdominal surgery.

Group I : Patients with BMI<30 Group II: Patients with BMI between 30 and 34.9 Group III: Patients with BMI between 35 and 39.9 Group IV: Patients with BMI between 40 and 49.9 Group V : Patients with BMI >50

After the end of surgery patients will be extubated and in the recovery room morphine PCA (patient-controlled analgesia) treatment will be started according to their adjusted body weight. When VAS values over 4,10 mg/kg Paracetamol IV will be used as an escape treatment. VAS values and Delivery and Demand of the PCA and additional need for analgesics will be recorded in the first 48 hours.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
March 2014
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Guniz M.Koksal

Assc.Prof

Istanbul University

Eligibility Criteria

Inclusion Criteria

  • patients undergoing abdominal surgery and who will be given PCA treatment for postoperative pain.

Exclusion Criteria

  • patients younger than 18 years old, patients with uncompensated diabetes or related polyneuropathy, patients receiving antidepressants or have a diagnosis of depression

Arms & Interventions

Group 5

Patients with BMI \> 50

Intervention: Morphine

Group IV

Patients with BMI between 40 and 49.9

Intervention: Morphine

Group III

Patients with BMI between 35 and 39.9

Intervention: Morphine

Group II

patients with BMI between 30 and 34.9

Intervention: Morphine

Group I

Patients with BMI \<30

Intervention: Morphine

Outcomes

Primary Outcomes

Pain Scores on the Visual Analog Scale

Time Frame: 48 hours

Correlation between the VAS Scores and BMI will evaluated

Study Sites (1)

Loading locations...

Similar Trials